Virtual screening and PIN indicated that naringin, chryso-obtusin glucoside, and rubrofusarin-6-O-β-D-gentiobioside were the main active compounds from CGE interacted with MAPK14 and MMP9, which provides the key mechanism of CGE for the treatment of respiratory diseases. Here, MAPK14 is linked to respiratory system disorder.